Fusobacterium nucleatum : Unraveling its potential role in gastric carcinogenesis.
Autor: | Petkevicius V; Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas 44307, Lithuania., Lehr K; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, Magdeburg 39120, Germany., Kupcinskas J; Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas 44307, Lithuania.; Institute for Digestive Research, Lithuanian University of Health Sciences, Kaunas 50161, Lithuania., Link A; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, Magdeburg 39120, Germany. alexander.link@med.ovgu.de. |
---|---|
Jazyk: | angličtina |
Zdroj: | World journal of gastroenterology [World J Gastroenterol] 2024 Sep 21; Vol. 30 (35), pp. 3972-3984. |
DOI: | 10.3748/wjg.v30.i35.3972 |
Abstrakt: | Fusobacterium nucleatum ( F. nucleatum ) is a Gram-negative anaerobic bacterium that plays a key role in the development of oral inflammation, such as periodontitis and gingivitis. In the last 10 years, F. nucleatum has been identified as a prevalent bacterium associated with colorectal adenocarcinoma and has also been linked to cancer progression, metastasis and poor disease outcome. While the role of F. nucleatum in colon carcinogenesis has been intensively studied, its role in gastric carcinogenesis is still poorly understood. Although Helicobacter pylori infection has historically been recognized as the strongest risk factor for the development of gastric cancer (GC), with recent advances in DNA sequencing technology, other members of the gastric microbial community, and F. nucleatum in particular, have received increasing attention. In this review, we summarize the existing knowledge on the involvement of F. nucleatum in gastric carcinogenesis and address the potential translational and clinical significance of F. nucleatum in GC. Competing Interests: Conflict-of-interest statement: Dr. Link reports grants from EFRE, grants from German Federal Ministry of Education and Research, personal fees from Janssen, personal fees from Ferring, personal fees from Luvos, during the conduct of the study. (©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |